No Data
No Data
A Quick Look at Today's Ratings for Arcutis Biotherapeutics(ARQT.US), With a Forecast Between $12 to $20
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Arcutis Biotherapeutics (ARQT)
Express News | Needham Reiterates Buy on Arcutis Biotherapeutics, Maintains $18 Price Target
Arcutis Biotherapeutics Analyst Ratings
Express News | Arcutis Biotherapeutics Shares Down 1.6% Premarket After Q2 Results
No Data